The risk or severity of adverse effects can be increased when mepivacaine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when thioridazine is combined with losartan.


The risk or severity of adverse effects can be increased when methocarbamol is combined with tizanidine.


The risk or severity of adverse effects can be increased when niflumic acid is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with Eprosartan.


The risk or severity of adverse effects can be increased when enalapril is combined with tolmetin.


The risk or severity of adverse effects can be increased when cetirizine is combined with maprotiline.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with HEROIN.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when lorazepam is combined with Agomelatine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with tizanidine.


The risk or severity of adverse effects can be increased when pyridostigmine is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with flurazepam.


The risk or severity of adverse effects can be increased when Olsalazine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when nitrazepam is combined with clomipramine.


The risk or severity of adverse effects can be increased when scopolamine is combined with dicyclomine.


The risk or severity of adverse effects can be increased when scopolamine is combined with tropicamide.


The risk or severity of adverse effects can be increased when oxaprozin is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when methadone is combined with dantrolene.


The risk or severity of adverse effects can be increased when Pizotifen is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when Telmisartan is combined with antipyrine.


The risk or severity of adverse effects can be increased when methimazole is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when sulindac is combined with resveratrol.


The risk or severity of adverse effects can be increased when Clofarabine is combined with nitric oxide.


The risk or severity of adverse effects can be increased when Clofarabine is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when rapamycin is combined with clozapine.


The risk or severity of adverse effects can be increased when quazepam is combined with maprotiline.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Riociguat.


The risk or severity of adverse effects can be increased when medrysone is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when medrysone is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when quazepam is combined with mesoridazine.


The risk or severity of adverse effects can be increased when scopolamine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when orphenadrine is combined with sertraline.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when Olmesartan is combined with carvedilol.


The risk or severity of adverse effects can be increased when oxycodone is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when nitrendipine is combined with losartan.


The risk or severity of adverse effects can be increased when nitrendipine is combined with thioridazine.


The risk or severity of adverse effects can be increased when epoprostenol is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when Melatonin is combined with Fospropofol.


The risk or severity of adverse effects can be increased when amifostine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when amifostine is combined with bumetanide.


The risk or severity of adverse effects can be increased when docetaxel is combined with TEMOPORFIN.


The risk or severity of adverse effects can be increased when nystatin is combined with felodipine.


The risk or severity of adverse effects can be increased when levorphanol is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when oxazepam is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when loxapine is combined with Flupentixol.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Eprosartan is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when nefazodone is combined with reserpine.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when procarbazine is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when butalbital is combined with tiagabine.


The risk or severity of adverse effects can be increased when tetracaine is combined with baclofen.


The risk or severity of adverse effects can be increased when Arotinolol is combined with diltiazem.


The risk or severity of adverse effects can be increased when butalbital is combined with zonisamide.


The risk or severity of adverse effects can be increased when loxapine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with HYDROXYPROGESTERONE CAPROATE.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with atenolol.


The risk or severity of adverse effects can be increased when propoxyphene is combined with furazolidone.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Halazepam.


The risk or severity of adverse effects can be increased when Paliperidone is combined with proparacaine.


The risk or severity of adverse effects can be increased when Propacetamol is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when brimonidine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when tolmetin is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when BUPRANOLOL is combined with Varenicline.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Metipranolol.


The risk or severity of adverse effects can be increased when naratriptan is combined with Iloperidone.


The risk or severity of adverse effects can be increased when dibucaine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when lorazepam is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Pirlindole is combined with linezolid.


The risk or severity of adverse effects can be increased when mirtazapine is combined with sumatriptan.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with acemetacin.


The risk or severity of adverse effects can be increased when lithium ion is combined with Fospropofol.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with Flupentixol.


The risk or severity of adverse effects can be increased when fosinopril is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when aspirin is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when atenolol is combined with metolazone.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with prazosin.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with enalapril.


The risk or severity of adverse effects can be increased when Propacetamol is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when oxycodone is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when morphine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Riociguat.


The risk or severity of adverse effects can be increased when Remoxipride is combined with scopolamine.


The risk or severity of adverse effects can be increased when isoflurane is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Aliskiren is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when amifostine is combined with ropinirole.


The risk or severity of adverse effects can be increased when salicylic acid is combined with eperisone.


The risk or severity of adverse effects can be increased when Olmesartan is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when tenoxicam is combined with diflunisal.


The risk or severity of adverse effects can be increased when docetaxel is combined with busulfan.


The risk or severity of adverse effects can be increased when docetaxel is combined with hydroxyurea.


The risk or severity of adverse effects can be increased when Tianeptine is combined with selegiline.


The risk or severity of adverse effects can be increased when docetaxel is combined with letrozole.


The risk or severity of adverse effects can be increased when haloperidol is combined with Fospropofol.


The risk or severity of adverse effects can be increased when nortriptyline is combined with felbamate.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when Olopatadine is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when Pipamperone is combined with nisoldipine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Olopatadine is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when acebutolol is combined with nylidrin.


The risk or severity of adverse effects can be increased when codeine is combined with thiamylal.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when risperidone is combined with zopiclone.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with triamcinolone.


The risk or severity of adverse effects can be increased when nefazodone is combined with desipramine.


The risk or severity of adverse effects can be increased when pirenzepine is combined with clozapine.


The risk or severity of adverse effects can be increased when THYMOL is combined with bepridil.


The risk or severity of adverse effects can be increased when butorphanol is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when butorphanol is combined with flunarizine.


The risk or severity of adverse effects can be increased when butorphanol is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when thalidomide is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with floxuridine.


The risk or severity of adverse effects can be increased when flunarizine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when bromocriptine is combined with midazolam.


The risk or severity of adverse effects can be increased when irbesartan is combined with benazepril.


The risk or severity of adverse effects can be increased when Lofexidine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when Lofexidine is combined with morphine.


The risk or severity of adverse effects can be increased when cocaine is combined with Articaine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with nifedipine.


The risk or severity of adverse effects can be increased when butalbital is combined with topiramate.


The risk or severity of adverse effects can be increased when moclobemide is combined with metaproterenol.


The risk or severity of adverse effects can be increased when diflunisal is combined with budesonide.


The risk or severity of adverse effects can be increased when suprofen is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Agomelatine.


The risk or severity of adverse effects can be increased when methysergide is combined with ritonavir.


The risk or severity of adverse effects can be increased when methysergide is combined with haloperidol.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when lorazepam is combined with amisulpride.


The risk or severity of adverse effects can be increased when isoflurane is combined with diphenhydramine.


The risk or severity of adverse effects can be increased when SOMATOSTATIN is combined with pentobarbital.


The risk or severity of adverse effects can be increased when fosinopril is combined with leflunomide.


The risk or severity of adverse effects can be increased when sertraline is combined with Lurasidone.


The risk or severity of adverse effects can be increased when ketamine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when aspirin is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when loteprednol is combined with memantine.


The risk or severity of adverse effects can be increased when ketamine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when THYMOL is combined with nimesulide.


The risk or severity of adverse effects can be increased when efavirenz is combined with clomipramine.


The risk or severity of adverse effects can be increased when Nabilone is combined with Eprosartan.


The risk or severity of adverse effects can be increased when clozapine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when warfarin is combined with Regorafenib.


The risk or severity of adverse effects can be increased when propoxyphene is combined with zotepine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with MELPERONE.


The risk or severity of adverse effects can be increased when mepivacaine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when nylidrin is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with nadolol.


The risk or severity of adverse effects can be increased when Paliperidone is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Clofarabine is combined with nitrendipine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with cinnarizine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with zonisamide.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Talniflumate is combined with carprofen.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Drospirenone.


The risk or severity of adverse effects can be increased when gabapentin is combined with Pipamperone.


The risk or severity of adverse effects can be increased when methylergonovine is combined with DALFOPRISTIN.


The risk or severity of adverse effects can be increased when reserpine is combined with Halazepam.


The risk or severity of adverse effects can be increased when ibuprofen is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when ethosuximide is combined with Flibanserin.


The risk or severity of adverse effects can be increased when tiapride is combined with fexofenadine.


The risk or severity of adverse effects can be increased when zotepine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when zotepine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with citalopram.


The risk or severity of adverse effects can be increased when diclofenac is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when tacrolimus is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when estrone is combined with mefloquine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with dexamethasone.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with minoxidil.


The risk or severity of adverse effects can be increased when Almotriptan is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when loxapine is combined with clonidine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with felbamate.


The risk or severity of adverse effects can be increased when mesoridazine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Spirapril is combined with leflunomide.


The risk or severity of adverse effects can be increased when amitriptyline is combined with meclizine.


The risk or severity of adverse effects can be increased when reserpine is combined with proparacaine.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when prilocaine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Flupentixol is combined with lidocaine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with clemastine.


The risk or severity of adverse effects can be increased when butorphanol is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Pirlindole is combined with bupropion.


The risk or severity of adverse effects can be increased when promethazine is combined with levodopa.


The risk or severity of adverse effects can be increased when tioconazole is combined with xylometazoline.


The risk or severity of adverse effects can be increased when morniflumate is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Normethadone.


The risk or severity of adverse effects can be increased when promethazine is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Articaine.


The risk or severity of adverse effects can be increased when epinephrine is combined with clenbuterol.


The risk or severity of adverse effects can be increased when Clobetasone is combined with enoxacin.


The risk or severity of adverse effects can be increased when quazepam is combined with Normethadone.


The risk or severity of adverse effects can be increased when lisinopril is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when clemastine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when loxapine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when nicardipine is combined with lisinopril.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when zaleplon is combined with HEROIN.


The risk or severity of adverse effects can be increased when mepivacaine is combined with brotizolam.


The risk or severity of adverse effects can be increased when nicardipine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when haloperidol is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with prilocaine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with ethotoin.


The risk or severity of adverse effects can be increased when diflorasone is combined with fleroxacin.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with HEROIN.


The risk or severity of adverse effects can be increased when METAXALONE is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Etomidate is combined with loratadine.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Difenoxin.


The risk or severity of adverse effects can be increased when methylergonovine is combined with midazolam.


The risk or severity of adverse effects can be increased when prazepam is combined with butamben.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when morphine is combined with theobromine.


The risk or severity of adverse effects can be increased when phenytoin is combined with cetirizine.


The risk or severity of adverse effects can be increased when phenytoin is combined with protriptyline.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when Talniflumate is combined with Masoprocol.


The risk or severity of adverse effects can be increased when chloroquine is combined with loteprednol.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with difluprednate.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with tolazoline.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when pimozide is combined with tiapride.


The risk or severity of adverse effects can be increased when pramipexole is combined with hydralazine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with amcinonide.


The risk or severity of adverse effects can be increased when pergolide is combined with betamethasone.


The risk or severity of adverse effects can be increased when Amrinone is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Bretylium.


The risk or severity of adverse effects can be increased when oxycodone is combined with vigabatrin.


The risk or severity of adverse effects can be increased when oxycodone is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when ritodrine is combined with oxymetazoline.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Regorafenib.


The risk or severity of adverse effects can be increased when oxycodone is combined with benzocaine.


The risk or severity of adverse effects can be increased when propantheline is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when methylergonovine is combined with azelastine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Ezetimibe.


The risk or severity of adverse effects can be increased when Clofarabine is combined with quinapril.


The risk or severity of adverse effects can be increased when Clofarabine is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Clofarabine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when olanzapine is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Clofarabine is combined with bumetanide.


The risk or severity of adverse effects can be increased when propofol is combined with amitriptyline.


The risk or severity of adverse effects can be increased when propofol is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with sertraline.


The risk or severity of adverse effects can be increased when propofol is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when ondansetron is combined with Articaine.


The risk or severity of adverse effects can be increased when Pramocaine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with medrysone.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when zaleplon is combined with Pizotifen.


The risk or severity of adverse effects can be increased when flurazepam is combined with clonazepam.


The risk or severity of adverse effects can be increased when triprolidine is combined with promethazine.


The risk or severity of adverse effects can be increased when rapamycin is combined with captopril.


The risk or severity of adverse effects can be increased when clomipramine is combined with tretinoin.


The risk or severity of adverse effects can be increased when levodopa is combined with nefazodone.


The risk or severity of adverse effects can be increased when amoxapine is combined with dobutamine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when benztropine is combined with pirenzepine.


The risk or severity of adverse effects can be increased when protriptyline is combined with methocarbamol.


The risk or severity of adverse effects can be increased when mesoridazine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when levorphanol is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when quazepam is combined with brotizolam.


The risk or severity of adverse effects can be increased when ethanol is combined with sertraline.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with periciazine.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Olopatadine.


The risk or severity of adverse effects can be increased when alprazolam is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Conivaptan is combined with dipyridamole.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when furosemide is combined with penbutolol.


The risk or severity of adverse effects can be increased when HEROIN is combined with Fospropofol.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with simvastatin.


The risk or severity of adverse effects can be increased when sulconazole is combined with nicardipine.


The risk or severity of adverse effects can be increased when amiodarone is combined with trandolapril.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with mecamylamine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Articaine.


The risk or severity of adverse effects can be increased when carprofen is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when procaine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when oxycodone is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when oxycodone is combined with thiothixene.


The risk or severity of adverse effects can be increased when leflunomide is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with clomipramine.


The risk or severity of adverse effects can be increased when quetiapine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when meprobamate is combined with promethazine.


The risk or severity of adverse effects can be increased when ipratropium is combined with nalbuphine.


The risk or severity of adverse effects can be increased when indapamide is combined with nadolol.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when niflumic acid is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when enflurane is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when niflumic acid is combined with Droxicam.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when niflumic acid is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Bortezomib is combined with Olmesartan.


The risk or severity of adverse effects can be increased when carprofen is combined with flumethasone.


The risk or severity of adverse effects can be increased when prilocaine is combined with zonisamide.


The risk or severity of adverse effects can be increased when Droxicam is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when Etomidate is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Tavaborole is combined with cinnarizine.


The risk or severity of adverse effects can be increased when chloroquine is combined with ketoprofen.


The risk or severity of adverse effects can be increased when amobarbital is combined with benzocaine.


The risk or severity of adverse effects can be increased when Vilazodone is combined with sumatriptan.


The risk or severity of adverse effects can be increased when Lurasidone is combined with maprotiline.


The risk or severity of adverse effects can be increased when amobarbital is combined with vigabatrin.


The risk or severity of adverse effects can be increased when desoximetasone is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when clomipramine is combined with clenbuterol.


The risk or severity of adverse effects can be increased when losartan is combined with fenbufen.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when epirizole is combined with equilin.


The risk or severity of adverse effects can be increased when antipyrine is combined with desoximetasone.


The risk or severity of adverse effects can be increased when penbutolol is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when bupivacaine is combined with triamterene.


The risk or severity of adverse effects can be increased when clomipramine is combined with Bambuterol.


The risk or severity of adverse effects can be increased when loxapine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when brotizolam is combined with butalbital.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with ambenonium.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with decamethonium.


The risk or severity of adverse effects can be increased when loxapine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when apomorphine is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when Olmesartan is combined with hydralazine.


The risk or severity of adverse effects can be increased when losartan is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when carbamazepine is combined with scopolamine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when brotizolam is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Olmesartan is combined with irbesartan.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with triflupromazine.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with butorphanol.


The risk or severity of adverse effects can be increased when quazepam is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when benzocaine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when Miltefosine is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when fenbufen is combined with halcinonide.


The risk or severity of adverse effects can be increased when protriptyline is combined with meclizine.


The risk or severity of adverse effects can be increased when benzocaine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when sevoflurane is combined with nortriptyline.


The risk or severity of adverse effects can be increased when sevoflurane is combined with benazepril.


The risk or severity of adverse effects can be increased when sevoflurane is combined with amoxapine.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when morphine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when meperidine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Naftifine.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Normethadone.


The risk or severity of adverse effects can be increased when Apremilast is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when pimozide is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Butethal is combined with methocarbamol.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with cilazapril.


The risk or severity of adverse effects can be increased when Butethal is combined with triprolidine.


The risk or severity of adverse effects can be increased when tropicamide is combined with pentazocine.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Etomidate.


The risk or severity of adverse effects can be increased when tropicamide is combined with mecamylamine.


The risk or severity of adverse effects can be increased when pentazocine is combined with bupivacaine.


The risk or severity of adverse effects can be increased when pentazocine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with SULFAMOXOLE.


The risk or severity of adverse effects can be increased when pentazocine is combined with Etomidate.


The risk or severity of adverse effects can be increased when indomethacin is combined with flumethasone.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with chlormezanone.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with Metipranolol.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Tixocortol.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Perospirone.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with Metipranolol.


The risk or severity of adverse effects can be increased when diclofenac is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when Tramadol is combined with butamben.


The risk or severity of adverse effects can be increased when isoflurane is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when isoflurane is combined with dibucaine.


The risk or severity of adverse effects can be increased when terazosin is combined with Aliskiren.


The risk or severity of adverse effects can be increased when isoflurane is combined with metolazone.


The risk or severity of adverse effects can be increased when isoflurane is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when benzocaine is combined with meclizine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with proparacaine.


The risk or severity of adverse effects can be increased when nabumetone is combined with Halobetasol.


The risk or severity of adverse effects can be increased when estazolam is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Halazepam.


The risk or severity of adverse effects can be increased when clorazepate is combined with halothane.


The risk or severity of adverse effects can be increased when clorazepate is combined with thiamylal.


The risk or severity of adverse effects can be increased when clorazepate is combined with desipramine.


The risk or severity of adverse effects can be increased when ethopropazine is combined with orphenadrine.


The risk or severity of adverse effects can be increased when Butoconazole is combined with cilnidipine.


The risk or severity of adverse effects can be increased when Artemether is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when clorazepate is combined with lidocaine.


The risk or severity of adverse effects can be increased when scopolamine is combined with paroxetine.


The risk or severity of adverse effects can be increased when selegiline is combined with lithium ion.


The risk or severity of adverse effects can be increased when triamterene is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when doxepin is combined with Difenoxin.


The risk or severity of adverse effects can be increased when norepinephrine is combined with isoproterenol.


The risk or severity of adverse effects can be increased when Butoconazole is combined with Lacidipine.


The risk or severity of adverse effects can be increased when tretinoin is combined with mecamylamine.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with spironolactone.


The risk or severity of adverse effects can be increased when diltiazem is combined with mecamylamine.


The risk or severity of adverse effects can be increased when diclofenac is combined with azelastine.


The risk or severity of adverse effects can be increased when lisinopril is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when diltiazem is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Pipamperone.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with dibucaine.


The risk or severity of adverse effects can be increased when carisoprodol is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when proparacaine is combined with flunarizine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when meperidine is combined with theobromine.


The risk or severity of adverse effects can be increased when buprenorphine is combined with pargyline.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with salicylamide.


The risk or severity of adverse effects can be increased when Metixene is combined with morphine.


The risk or severity of adverse effects can be increased when zotepine is combined with desipramine.


The risk or severity of adverse effects can be increased when temazepam is combined with triprolidine.


The risk or severity of adverse effects can be increased when midazolam is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with estramustine.


The risk or severity of adverse effects can be increased when temazepam is combined with methocarbamol.


The risk or severity of adverse effects can be increased when doxepin is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Normethadone.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with decamethonium.


The risk or severity of adverse effects can be increased when apraclonidine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when apraclonidine is combined with felodipine.


The risk or severity of adverse effects can be increased when carbamazepine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with gentamicin.


The risk or severity of adverse effects can be increased when ipratropium is combined with tropicamide.


The risk or severity of adverse effects can be increased when Telmisartan is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when carbamazepine is combined with procarbazine.


The risk or severity of adverse effects can be increased when ipratropium is combined with dicyclomine.


The risk or severity of adverse effects can be increased when pimozide is combined with Fospropofol.


The risk or severity of adverse effects can be increased when ipratropium is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when indomethacin is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when ketamine is combined with protriptyline.


The risk or severity of adverse effects can be increased when ketamine is combined with cetirizine.


The risk or severity of adverse effects can be increased when midazolam is combined with sevoflurane.


The risk or severity of adverse effects can be increased when clemastine is combined with tizanidine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when docetaxel is combined with Calcipotriol.


The risk or severity of adverse effects can be increased when cilostazol is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when benzocaine is combined with promethazine.


The risk or severity of adverse effects can be increased when benzocaine is combined with clonazepam.


The risk or severity of adverse effects can be increased when codeine is combined with triamterene.


The risk or severity of adverse effects can be increased when Halazepam is combined with butamben.


The risk or severity of adverse effects can be increased when isradipine is combined with propranolol.


The risk or severity of adverse effects can be increased when epirizole is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with triamterene.


The risk or severity of adverse effects can be increased when isradipine is combined with clonidine.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with epirizole.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with proparacaine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with ethosuximide.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with methimazole.


The risk or severity of adverse effects can be increased when Eprosartan is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when pergolide is combined with sulfinpyrazone.


The risk or severity of adverse effects can be increased when ATROPINE is combined with oxyphenonium.


The risk or severity of adverse effects can be increased when Eprosartan is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when alprenolol is combined with acetylcholine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with thiopental.


The risk or severity of adverse effects can be increased when Limaprost is combined with EDOXABAN.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when temazepam is combined with nitrazepam.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with nifedipine.


The risk or severity of adverse effects can be increased when pergolide is combined with clofazimine.


The risk or severity of adverse effects can be increased when alclometasone is combined with physostigmine.


The risk or severity of adverse effects can be increased when Almotriptan is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when Droxicam is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when Almotriptan is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when Almotriptan is combined with thiothixene.


The risk or severity of adverse effects can be increased when Almotriptan is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when butabarbital is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when butabarbital is combined with pentobarbital.


The risk or severity of adverse effects can be increased when sulpiride is combined with tizanidine.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with triamterene.


The risk or severity of adverse effects can be increased when daunorubicin is combined with clozapine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Eletriptan.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with citalopram.


The risk or severity of adverse effects can be increased when venlafaxine is combined with PHENPROCOUMON.


The risk or severity of adverse effects can be increased when hydromorphone is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when Benidipine is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when methylergonovine is combined with antipyrine.


The risk or severity of adverse effects can be increased when docetaxel is combined with methyltestosterone.


The risk or severity of adverse effects can be increased when Fingolimod is combined with leflunomide.


The risk or severity of adverse effects can be increased when Perospirone is combined with fexofenadine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with METAXALONE.


The risk or severity of adverse effects can be increased when naratriptan is combined with Levomepromazine.


The risk or severity of adverse effects can be increased when oxazepam is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Sacubitril is combined with isradipine.


The risk or severity of adverse effects can be increased when midazolam is combined with flurazepam.


The risk or severity of adverse effects can be increased when midazolam is combined with tizanidine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Olmesartan.


The risk or severity of adverse effects can be increased when meclizine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Alvimopan.


The risk or severity of adverse effects can be increased when Butoconazole is combined with nimodipine.


The risk or severity of adverse effects can be increased when minoxidil is combined with sotalol.


The risk or severity of adverse effects can be increased when azelastine is combined with alclofenac.


The risk or severity of adverse effects can be increased when doxazosin is combined with methazolamide.


The risk or severity of adverse effects can be increased when doxazosin is combined with Eplerenone.


The risk or severity of adverse effects can be increased when Vorapaxar is combined with Apixaban.


The risk or severity of adverse effects can be increased when haloperidol is combined with ethotoin.


The risk or severity of adverse effects can be increased when ramipril is combined with ibuprofen.


The risk or severity of adverse effects can be increased when diazepam is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Atracurium besylate.


The risk or severity of adverse effects can be increased when Salsalate is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with Ramelteon.


The risk or severity of adverse effects can be increased when captopril is combined with ketoprofen.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with zonisamide.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with tiagabine.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with equilin.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when cisapride is combined with atorvastatin.


The risk or severity of adverse effects can be increased when tubocurarine is combined with Varenicline.


The risk or severity of adverse effects can be increased when amobarbital is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with Asenapine.


The risk or severity of adverse effects can be increased when betamethasone is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when HEROIN is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Olsalazine.


The risk or severity of adverse effects can be increased when procyclidine is combined with Tapentadol.


The risk or severity of adverse effects can be increased when ropinirole is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when fenbufen is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when morniflumate is combined with mesalamine.


The risk or severity of adverse effects can be increased when codeine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when clemastine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with ethosuximide.


The risk or severity of adverse effects can be increased when tolmetin is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when methadone is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when etodolac is combined with ibuprofen.


The risk or severity of adverse effects can be increased when xylometazoline is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when methadone is combined with metoclopramide.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with thiopental.


The risk or severity of adverse effects can be increased when Ramelteon is combined with paroxetine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with triprolidine.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with butalbital.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Pizotifen.


The risk or severity of adverse effects can be increased when codeine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when Phenelzine is combined with haloperidol.


The risk or severity of adverse effects can be increased when amisulpride is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Phenelzine is combined with triflupromazine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with rapamycin.


The risk or severity of adverse effects can be increased when benzocaine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when isoflurane is combined with perphenazine.


The risk or severity of adverse effects can be increased when venlafaxine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with mebendazole.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Pemetrexed.


The risk or severity of adverse effects can be increased when Eletriptan is combined with lithium ion.


The risk or severity of adverse effects can be increased when ibuprofen is combined with resveratrol.


The risk or severity of adverse effects can be increased when venlafaxine is combined with oxycodone.


The risk or severity of adverse effects can be increased when nifedipine is combined with captopril.


The risk or severity of adverse effects can be increased when Echothiophate is combined with methacholine.


The risk or severity of adverse effects can be increased when antipyrine is combined with haloperidol.


The risk or severity of adverse effects can be increased when nalbuphine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with methazolamide.


The risk or severity of adverse effects can be increased when Tianeptine is combined with AMPHETAMINE.


The risk or severity of adverse effects can be increased when suprofen is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Droxicam.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Torasemide.


The risk or severity of adverse effects can be increased when zaleplon is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with theobromine.


The risk or severity of adverse effects can be increased when Vecuronium is combined with methscopolamine.


The risk or severity of adverse effects can be increased when zopiclone is combined with chlormezanone.


The risk or severity of adverse effects can be increased when buprenorphine is combined with Phenelzine.


The risk or severity of adverse effects can be increased when midodrine is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with niflumic acid.


The risk or severity of adverse effects can be increased when Tramadol is combined with sulpiride.


The risk or severity of adverse effects can be increased when linezolid is combined with tiapride.


The risk or severity of adverse effects can be increased when zopiclone is combined with Escitalopram.


The risk or severity of adverse effects can be increased when amobarbital is combined with Lurasidone.


The risk or severity of adverse effects can be increased when zopiclone is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when buspirone is combined with cetirizine.


The risk or severity of adverse effects can be increased when Pirlindole is combined with dipivefrin.


The risk or severity of adverse effects can be increased when oxybutynin is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when butorphanol is combined with METAXALONE.


The risk or severity of adverse effects can be increased when propranolol is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when lithium ion is combined with Pizotifen.


The risk or severity of adverse effects can be increased when thiothixene is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when brotizolam is combined with Olopatadine.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with loratadine.


The risk or severity of adverse effects can be increased when chlorpheniramine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Apremilast is combined with amcinonide.


The risk or severity of adverse effects can be increased when Apremilast is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when diflunisal is combined with ketoprofen.


The risk or severity of adverse effects can be increased when propoxyphene is combined with PAMABROM.


The risk or severity of adverse effects can be increased when Telmisartan is combined with salicylic acid.


The risk or severity of adverse effects can be increased when Lofexidine is combined with Sacubitril.


The risk or severity of adverse effects can be increased when buspirone is combined with naratriptan.


The risk or severity of adverse effects can be increased when buspirone is combined with rizatriptan.


The risk or severity of adverse effects can be increased when buspirone is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with fosinopril.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with tizanidine.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Pipamperone.


The risk or severity of adverse effects can be increased when spiramycin is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Tramadol is combined with dyclonine.


The risk or severity of adverse effects can be increased when Trospium is combined with buprenorphine.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with indapamide.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Lofexidine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when amobarbital is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when haloperidol is combined with estazolam.


The risk or severity of adverse effects can be increased when halothane is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Retigabine.


The risk or severity of adverse effects can be increased when furosemide is combined with Clevidipine.


The risk or severity of adverse effects can be increased when midazolam is combined with procaine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when clotrimazole is combined with oxycodone.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with risperidone.


The risk or severity of adverse effects can be increased when quetiapine is combined with cetirizine.


The risk or severity of adverse effects can be increased when enflurane is combined with sulpiride.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with MELPERONE.


The risk or severity of adverse effects can be increased when azelastine is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when azelastine is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when enflurane is combined with carisoprodol.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with topiramate.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with mepivacaine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Desloratadine.


The risk or severity of adverse effects can be increased when prazepam is combined with desipramine.


The risk or severity of adverse effects can be increased when nimodipine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with topiramate.


The risk or severity of adverse effects can be increased when trazodone is combined with tetracaine.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with irbesartan.


The risk or severity of adverse effects can be increased when barnidipine is combined with hydralazine.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with alclofenac.


The risk or severity of adverse effects can be increased when Phenelzine is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when Phenelzine is combined with rasagiline.


The risk or severity of adverse effects can be increased when desipramine is combined with dantrolene.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with rizatriptan.


The risk or severity of adverse effects can be increased when alprazolam is combined with efavirenz.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with isoniazid.


The risk or severity of adverse effects can be increased when Toloxatone is combined with mianserin.


The risk or severity of adverse effects can be increased when cocaine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with etizolam.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when alprazolam is combined with clorazepate.


The risk or severity of adverse effects can be increased when nabumetone is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when cetirizine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when cocaine is combined with Melatonin.


The risk or severity of adverse effects can be increased when cocaine is combined with clonazepam.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with zotepine.


The risk or severity of adverse effects can be increased when nabumetone is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with fluocinonide.


The risk or severity of adverse effects can be increased when Halazepam is combined with levodopa.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when benzoic acid is combined with eperisone.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Micafungin is combined with bepridil.


The risk or severity of adverse effects can be increased when gabapentin is combined with clomipramine.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with reserpine.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with Tapentadol.


The risk or severity of adverse effects can be increased when Tolcapone is combined with metoprolol.


The risk or severity of adverse effects can be increased when trimipramine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Tramadol is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with papaverine.


The risk or severity of adverse effects can be increased when dexamethasone is combined with physostigmine.


The risk or severity of adverse effects can be increased when Clobetasone is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when dexamethasone is combined with rivastigmine.


The risk or severity of adverse effects can be increased when diflunisal is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when levorphanol is combined with ondansetron.


The risk or severity of adverse effects can be increased when levorphanol is combined with cocaine.


The risk or severity of adverse effects can be increased when levorphanol is combined with tiagabine.


The risk or severity of adverse effects can be increased when levorphanol is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when topiramate is combined with felbamate.


The risk or severity of adverse effects can be increased when loratadine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Halazepam is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when nisoldipine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when SOMATOSTATIN is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when Clofarabine is combined with thalidomide.


The risk or severity of adverse effects can be increased when SOMATOSTATIN is combined with amobarbital.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with azelastine.


The risk or severity of adverse effects can be increased when Masoprocol is combined with azelastine.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with cilostazol.


The risk or severity of adverse effects can be increased when protriptyline is combined with Retigabine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Normethadone.


The risk or severity of adverse effects can be increased when methysergide is combined with rivastigmine.


The risk or severity of adverse effects can be increased when thioridazine is combined with clonazepam.


The risk or severity of adverse effects can be increased when tolmetin is combined with flumethasone.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with oxycodone.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when benzocaine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with aspirin.


The risk or severity of adverse effects can be increased when amphotericin b is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Ephedrine is combined with METHAMPHETAMINE.


The risk or severity of adverse effects can be increased when Treprostinil is combined with sulindac.


The risk or severity of adverse effects can be increased when tubocurarine is combined with methacholine.


The risk or severity of adverse effects can be increased when nimodipine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when tubocurarine is combined with Fesoterodine.


The risk or severity of adverse effects can be increased when nimodipine is combined with Metipranolol.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with minoxidil.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with clomiphene.


The risk or severity of adverse effects can be increased when butamben is combined with Difenoxin.


The risk or severity of adverse effects can be increased when carprofen is combined with difluprednate.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with zotepine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Clobetasone.


The risk or severity of adverse effects can be increased when oxprenolol is combined with floctafenine.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with Telmisartan.


The risk or severity of adverse effects can be increased when codeine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with apraclonidine.


The risk or severity of adverse effects can be increased when rasagiline is combined with PIRBUTEROL.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Naftifine.


The risk or severity of adverse effects can be increased when buspirone is combined with clidinium.


The risk or severity of adverse effects can be increased when Linagliptin is combined with cilazapril.


The risk or severity of adverse effects can be increased when tacrolimus is combined with tretinoin.


The risk or severity of adverse effects can be increased when ketorolac is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when trandolapril is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with ethinyl estradiol.


The risk or severity of adverse effects can be increased when Linagliptin is combined with Spirapril.


The risk or severity of adverse effects can be increased when mepivacaine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when morphine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when mesalamine is combined with formestane.


The risk or severity of adverse effects can be increased when mesalamine is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when sulconazole is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when clotrimazole is combined with Lacidipine.


The risk or severity of adverse effects can be increased when Isoconazole is combined with Amrinone.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with Ramelteon.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with dipyridamole.


The risk or severity of adverse effects can be increased when sertraline is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when metoclopramide is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when resveratrol is combined with diflorasone.


The risk or severity of adverse effects can be increased when docetaxel is combined with Ecabet.


The risk or severity of adverse effects can be increased when thiothixene is combined with tetracaine.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with Aliskiren.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when quazepam is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with diflorasone.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when medrysone is combined with Demecarium.


The risk or severity of adverse effects can be increased when sulpiride is combined with proparacaine.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when furosemide is combined with terazosin.


The risk or severity of adverse effects can be increased when metoclopramide is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with difluprednate.


The risk or severity of adverse effects can be increased when morphine is combined with zonisamide.


The risk or severity of adverse effects can be increased when quetiapine is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when HEROIN is combined with triamterene.


The risk or severity of adverse effects can be increased when zaleplon is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when lithium ion is combined with carisoprodol.


The risk or severity of adverse effects can be increased when lidocaine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Fospropofol is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when Boceprevir is combined with toremifene.


The risk or severity of adverse effects can be increased when aspirin is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when thalidomide is combined with Aliskiren.


The risk or severity of adverse effects can be increased when Eletriptan is combined with Tapentadol.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Boceprevir is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when isradipine is combined with tizanidine.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with galanthamine.


The risk or severity of adverse effects can be increased when diltiazem is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when clomipramine is combined with Efonidipine.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when PERHEXILINE is combined with atorvastatin.


The risk or severity of adverse effects can be increased when triamterene is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Lurasidone.


The risk or severity of adverse effects can be increased when promazine is combined with Flupentixol.


The risk or severity of adverse effects can be increased when alclofenac is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with leflunomide.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with thioguanine.


The risk or severity of adverse effects can be increased when buspirone is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Pentolinium is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Fospropofol is combined with primidone.


The risk or severity of adverse effects can be increased when methscopolamine is combined with levorphanol.


The risk or severity of adverse effects can be increased when pentobarbital is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with alclofenac.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with phenytoin.


The risk or severity of adverse effects can be increased when docetaxel is combined with Lanreotide.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when amisulpride is combined with amoxapine.


The risk or severity of adverse effects can be increased when ambroxol is combined with atorvastatin.


The risk or severity of adverse effects can be increased when fenoldopam is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when amisulpride is combined with nortriptyline.


The risk or severity of adverse effects can be increased when halothane is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when tetracaine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when reserpine is combined with levorphanol.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with felbamate.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when reserpine is combined with perphenazine.


The risk or severity of adverse effects can be increased when docetaxel is combined with methotrexate.


The risk or severity of adverse effects can be increased when oxymorphone is combined with scopolamine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when formestane is combined with donepezil.


The risk or severity of adverse effects can be increased when oxymorphone is combined with D-mannitol.


The risk or severity of adverse effects can be increased when diflunisal is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when docetaxel is combined with anastrozole.


The risk or severity of adverse effects can be increased when Tofacitinib is combined with leflunomide.


The risk or severity of adverse effects can be increased when Difenoxin is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when rapamycin is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when Difenoxin is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when promethazine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when sevoflurane is combined with chlormezanone.


The risk or severity of adverse effects can be increased when sevoflurane is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when secobarbital is combined with triflupromazine.


The risk or severity of adverse effects can be increased when itraconazole is combined with gabapentin.


The risk or severity of adverse effects can be increased when methysergide is combined with caffeine.


The risk or severity of adverse effects can be increased when methysergide is combined with sildenafil.


The risk or severity of adverse effects can be increased when methysergide is combined with azithromycin.


The risk or severity of adverse effects can be increased when methysergide is combined with ticlopidine.


The risk or severity of adverse effects can be increased when lithium ion is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when pergolide is combined with Ticagrelor.


The risk or severity of adverse effects can be increased when rasagiline is combined with Sacubitril.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Sacubitril.


The risk or severity of adverse effects can be increased when Etidocaine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Etomidate.


The risk or severity of adverse effects can be increased when salicylamide is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with Escitalopram.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with amisulpride.


The risk or severity of adverse effects can be increased when Melatonin is combined with clemastine.


The risk or severity of adverse effects can be increased when oxycodone is combined with furosemide.


The risk or severity of adverse effects can be increased when Melatonin is combined with venlafaxine.


The risk or severity of adverse effects can be increased when pergolide is combined with tofisopam.


The risk or severity of adverse effects can be increased when Conivaptan is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when cerulenin is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when Conivaptan is combined with Tolcapone.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with aspirin.


The risk or severity of adverse effects can be increased when Nabilone is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when PSEUDOEPHEDRINE is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when QUINETHAZONE is combined with deslanoside.


The risk or severity of adverse effects can be increased when procaine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Salsalate is combined with resveratrol.


The risk or severity of adverse effects can be increased when propoxyphene is combined with halothane.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with metoclopramide.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Ramelteon.


The risk or severity of adverse effects can be increased when methylergonovine is combined with acetaminophen.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with nicardipine.


The risk or severity of adverse effects can be increased when zotepine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with efavirenz.


The risk or severity of adverse effects can be increased when metronidazole is combined with Carbocisteine.


The risk or severity of adverse effects can be increased when prazepam is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when prazepam is combined with flunarizine.


The risk or severity of adverse effects can be increased when prazepam is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Lacidipine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when fosinopril is combined with quetiapine.


The risk or severity of adverse effects can be increased when metoclopramide is combined with MELPERONE.


The risk or severity of adverse effects can be increased when terconazole is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when dibucaine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when Melatonin is combined with ethotoin.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when clomipramine is combined with valsartan.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with flumethasone.


The risk or severity of adverse effects can be increased when loxapine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when loxapine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when isoflurane is combined with propoxyphene.


The risk or severity of adverse effects can be increased when isoflurane is combined with dyclonine.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when diclofenac is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when cetirizine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with Nebivolol.


The risk or severity of adverse effects can be increased when levorphanol is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when levorphanol is combined with ethosuximide.


The risk or severity of adverse effects can be increased when methysergide is combined with clotiazepam.


The risk or severity of adverse effects can be increased when docetaxel is combined with Vorinostat.


The risk or severity of adverse effects can be increased when thalidomide is combined with Torasemide.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Perospirone.


The risk or severity of adverse effects can be increased when levorphanol is combined with thiopental.


The risk or severity of adverse effects can be increased when bupivacaine is combined with minoxidil.


The risk or severity of adverse effects can be increased when cilazapril is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when cilazapril is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when bupivacaine is combined with terazosin.


The risk or severity of adverse effects can be increased when ATROPINE is combined with meperidine.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with Clobetasone.


The risk or severity of adverse effects can be increased when Lurasidone is combined with trazodone.


The risk or severity of adverse effects can be increased when oxymorphone is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with apraclonidine.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with Telmisartan.


The risk or severity of adverse effects can be increased when galanthamine is combined with Varenicline.


The risk or severity of adverse effects can be increased when oxymorphone is combined with procarbazine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when Butethal is combined with desipramine.


The risk or severity of adverse effects can be increased when apomorphine is combined with phenoxybenzamine.


The risk or severity of adverse effects can be increased when losartan is combined with fenoprofen.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with estazolam.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with Iloperidone.


The risk or severity of adverse effects can be increased when losartan is combined with Propacetamol.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when Paliperidone is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with dantrolene.


The risk or severity of adverse effects can be increased when Torasemide is combined with quetiapine.


The risk or severity of adverse effects can be increased when flurazepam is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with nefazodone.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with doxepin.


The risk or severity of adverse effects can be increased when Etomidate is combined with sulpiride.


The risk or severity of adverse effects can be increased when floctafenine is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when Etomidate is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Tixocortol is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when fludiazepam is combined with primidone.


The risk or severity of adverse effects can be increased when salicylamide is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when griseofulvin is combined with isradipine.